Sacramento, CALIFORNIA3 Active Studies

Geographic Atrophy Clinical Trials in Sacramento, CALIFORNIA

Find 3 actively recruiting geographic atrophy clinical trials in Sacramento, CALIFORNIA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
1,735
Enrolling

Recruiting Geographic Atrophy Studies in Sacramento

About Geographic Atrophy Clinical Trials in Sacramento

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 3 geographic atrophy clinical trials recruiting participants in Sacramento, CALIFORNIA. These studies are seeking a combined 1,735 participants. Research is being sponsored by Annexon, Inc., AstraZeneca, Alpine Immune Sciences Inc, A Subsidiary of Vertex. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Sacramento — FAQ

Are there geographic atrophy clinical trials in Sacramento?

Yes, there are 3 geographic atrophy clinical trials currently recruiting in Sacramento, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sacramento?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you about next steps.

Are clinical trials in Sacramento free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sacramento studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 3 active trials in Sacramento are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated March 2, 2026 from ClinicalTrials.gov